| Title |
Antipsychotics for acute and chronic pain in adults
|
|---|---|
| Published in |
Cochrane database of systematic reviews, August 2013
|
| DOI | 10.1002/14651858.cd004844.pub3 |
| Pubmed ID | |
| Authors |
Stefan Seidel, Martin Aigner, Michael Ossege, Elisabeth Pernicka, Brigitte Wildner, Thomas Sycha |
| Abstract |
This is an updated version of the original Cochrane review published in Issue 4, 2008. The role of antipsychotics as adjuvant analgesics is a subject of longstanding controversy. Neuroleptanalgesia (that is a state of quiescence, altered awareness, and analgesia produced by a combination of taking an opioid analgesic and an antipsychotic), an established term for the management of acute pain, was shown to negatively influence disease course and total mortality in unstable angina patients. Nevertheless, antipsychotics are used to treat chronic pain (for example chronic headache, fibromyalgia and diabetic neuropathia). With atypical antipsychotics, a new class of antipsychotics, both fewer extrapyramidal side effects and additional benefits may be available. |
X Demographics
The data shown below were collected from the profiles of 29 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 28% |
| United Kingdom | 5 | 17% |
| Canada | 2 | 7% |
| France | 1 | 3% |
| Ireland | 1 | 3% |
| Japan | 1 | 3% |
| Saudi Arabia | 1 | 3% |
| Guatemala | 1 | 3% |
| Virgin Islands, U.S. | 1 | 3% |
| Other | 0 | 0% |
| Unknown | 8 | 28% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 66% |
| Scientists | 5 | 17% |
| Practitioners (doctors, other healthcare professionals) | 3 | 10% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
| Unknown | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 255 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Austria | 1 | <1% |
| Unknown | 252 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 33 | 13% |
| Researcher | 32 | 13% |
| Student > Bachelor | 27 | 11% |
| Student > Ph. D. Student | 21 | 8% |
| Student > Postgraduate | 19 | 7% |
| Other | 47 | 18% |
| Unknown | 76 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 96 | 38% |
| Nursing and Health Professions | 23 | 9% |
| Psychology | 13 | 5% |
| Neuroscience | 12 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 2% |
| Other | 19 | 7% |
| Unknown | 86 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2021.
All research outputs
#1,429,846
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#3,063
of 11,842 outputs
Outputs of similar age
#12,256
of 212,370 outputs
Outputs of similar age from Cochrane database of systematic reviews
#67
of 234 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,370 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 234 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.